NDANASALSPRAY, METEREDPriority Review
Approved
Nov 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NARCAN is a metered nasal spray formulation of naloxone hydrochloride, an opioid antagonist approved by the FDA in 2015. It rapidly reverses opioid overdose by competitively blocking opioid receptors in the central nervous system. The nasal route enables rapid, non-invasive administration in emergency settings, making it a critical public health tool.
Peak
NARCAN is in peak commercial phase with established market presence; the brand team is likely stable or consolidating, focused on market penetration and public health initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg
Started Oct 2022
24 enrolled
Opioid Overdose
Career Relevance
Working on NARCAN offers exposure to high-impact public health commercialization, government relations, and crisis response marketing. The product is in a mature, stable phase, making it suitable for professionals seeking to build expertise in market maintenance, policy advocacy, and community-based distribution models.
Brand Manager
Worked on NARCAN at Emergent BioSolutions? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.